Relief TherapeuticsSupporting patients through science and innovation
Relief Therapeutics is a drug development company focusing on clinical stage projects, primarily developing drugs of natural human origin (peptides and proteins) with a history of clinical testing and use in human patients.
Currently Relief Therapeutics concentrates its initial efforts on diabetic complications and respiratory diseases. A focus on additional MPCs and indications will be considered as opportunities develop.
Main development programs I:
Relief places a special emphasis to rapidly deliver on these programs with the highest priority. They constitute the main strategical focus of the company.
Main development programs II:
Although Relief is conscious that these programs have a great potential to benefit patients, in a resource-limited environment Relief has decided to pause development in these indications for now. Relief is committed to look for new resources in order to rapidly resume these programs.